Abstract 5762: RPPA kinomic profiling of a tumor eradication phenotype induced by SIAH inhibition, a major tumor vulnerability in the EGFR/HER2/RAS signaling pathway, in late-stage and metastatic human cancer cell lines
Jonathan M. Baker(Old Dominion University), Amy Tang(University of Southern California), Julia Wulfkuhle(University of California, San Francisco), Rosa I. Gallagher(George Mason University), Ashleigh Hannah(Old Dominion University), Andrew Howell(Old Dominion University), Emanuel F. Petricoin(Center for Biologics Evaluation and Research)
Cited by 0
Related Papers
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
|The Lancet Oncology|2020|541
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|Cancer Cell|2021|330